The interrelations between high- and low-molecular weight forms of normal and mutant (Krabbe-disease) galactocerebrosidase
- PMID: 7458907
- PMCID: PMC1161912
- DOI: 10.1042/bj1890009
The interrelations between high- and low-molecular weight forms of normal and mutant (Krabbe-disease) galactocerebrosidase
Abstract
Galactocerebrosidase (beta-d-galactosyl-N-acylsphingosine galactohydrolase; EC 3.2.1.46) activity of brain and liver preparations from normal individuals and patients with Krabbe disease (globoid-cell leukodystrophy) have been separated by gel filtration into four different molecular-weight forms. The apparent mol.wts. were 760000+/-34000 and 121000+/-10000 for the high- and low-molecular-weight forms (peaks I and IV respectively) and 499000+/-22000 (mean+/-s.d.) and 256000+/-12000 for the intermediate forms (peaks II and III respectively). On examination by sodium dodecyl sulphate/polyacrylamide-gel electrophoresis, the high- and low-molecular-weight forms revealed a single protein band with a similar mobility corresponding to a mol.wt. of about 125000. Antigenic identity was demonstrated between the various molecular-weight forms of the normal and the mutant galactocerebrosidases by using antisera against either the high- or the low-molecular-weight enzymes. The high-molecular-weight form of galactocerebrosidase was found to possess higher specific activity toward natural substrates when compared with the low-molecular-weight form. It is suggested that the high-molecular-weight enzyme is the active form in vivo and an aggregation process that proceeds from a monomer (mol.wt. approx. 125000) to a dimer (mol.wt. approx. 250000) and from the dimer to either a tetramer (mol.wt. approx. 500000) or a hexamer (mol.wt. approx. 750000) takes place in normal as well as in Krabbe-disease tissues.
Similar articles
-
Galactosylceramide beta-galactosidase in Krabbe disease: partial purification and characterization of the mutant enzyme.Arch Biochem Biophys. 1979 Aug;196(1):93-101. doi: 10.1016/0003-9861(79)90555-1. Arch Biochem Biophys. 1979. PMID: 507819 No abstract available.
-
Galactocerebrosidase activity in canine globoid leukodystrophy.Neurology. 1977 Aug;27(8):758-66. doi: 10.1212/wnl.27.8.758. Neurology. 1977. PMID: 560646
-
Sphingolipid beta-D-galactosidases in globoid cell leukodystrophy (Krabbe disease).Birth Defects Orig Artic Ser. 1978;14(6B):113-26. Birth Defects Orig Artic Ser. 1978. PMID: 103589 No abstract available.
-
[Krabbe disease (globoid cell leukodystrophy)].Nihon Rinsho. 1995 Dec;53(12):2947-51. Nihon Rinsho. 1995. PMID: 8577041 Review. Japanese.
-
Pathogenesis of leukodystrophy for Krabbe disease: molecular mechanism and clinical treatment.Brain Dev. 2009 Aug;31(7):485-7. doi: 10.1016/j.braindev.2009.03.001. Epub 2009 Mar 29. Brain Dev. 2009. PMID: 19332366 Review.
Cited by
-
Self-association of human beta-galactocerebrosidase: Dependence on pH, salt, and surfactant.PLoS One. 2019 Dec 23;14(12):e0226618. doi: 10.1371/journal.pone.0226618. eCollection 2019. PLoS One. 2019. PMID: 31869371 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical